These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37678195)

  • 1. Advances in the treatment of gastric cancer: 2022-2023.
    Ilson DH
    Curr Opin Gastroenterol; 2023 Nov; 39(6):517-521. PubMed ID: 37678195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the treatment of gastric cancer.
    Ilson DH
    Curr Opin Gastroenterol; 2018 Nov; 34(6):465-468. PubMed ID: 30303856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the treatment of gastric cancer.
    Ilson DH
    Curr Opin Gastroenterol; 2020 Nov; 36(6):525-529. PubMed ID: 32889823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the treatment of gastric cancer: 2020-2021.
    Ilson DH
    Curr Opin Gastroenterol; 2021 Nov; 37(6):615-618. PubMed ID: 34456227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to use anti-PD-1 therapy in gastric cancer: the approach in the United States.
    Ilson DH
    Chin Clin Oncol; 2024 Feb; 13(1):7. PubMed ID: 38453657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the treatment of gastric cancer: 2019.
    Ilson DH
    Curr Opin Gastroenterol; 2019 Nov; 35(6):551-554. PubMed ID: 31436556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the therapeutic landscape of oesophago-gastric cancers.
    Fokter Dovnik N; Smyth EC
    Curr Opin Oncol; 2021 Jul; 33(4):362-367. PubMed ID: 33720069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Phase II Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab and Chemoradiotherapy in the Adjuvant Setting in Operated Patients With HER2-positive Gastric or Gastroesophageal Junction Cancer (TOXAG Study): A Turkish Oncology Group Study.
    Abali H; Yalcin S; Onal HC; Dane F; Oksuzoglu B; Ozdemir N; Mertsoylu H; Artac M; Camci C; Karabulut B; Basal FB; Budakoglu B; Sendur MAN; Goktas B; Ozdener F; Baygul A
    Am J Clin Oncol; 2021 Jul; 44(7):301-307. PubMed ID: 33979100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma.
    Sahin U; Türeci Ö; Manikhas G; Lordick F; Rusyn A; Vynnychenko I; Dudov A; Bazin I; Bondarenko I; Melichar B; Dhaene K; Wiechen K; Huber C; Maurus D; Arozullah A; Park JW; Schuler M; Al-Batran SE
    Ann Oncol; 2021 May; 32(5):609-619. PubMed ID: 33610734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group.
    Wagner AD; Grabsch HI; Mauer M; Marreaud S; Caballero C; Thuss-Patience P; Mueller L; Elme A; Moehler MH; Martens U; Kang YK; Rha SY; Cats A; Tokunaga M; Lordick F
    BMC Cancer; 2019 May; 19(1):494. PubMed ID: 31126258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zolbetuximab plus chemotherapy for locally advanced unresectable or metastatic stomach or gastroesophageal junction cancers: a plain language summary.
    Shitara K; Shah MA; Lordick F; Bang YJ; Ilson D; Cutsem EV; Enzinger P; Kim SS; Klempner SJ; Moran D; Park JW; Bhattacharya P; Ajani JA; Xu RH
    Future Oncol; 2024 May; ():1-17. PubMed ID: 38861294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the treatment of gastric cancer.
    Ilson DH
    Curr Opin Gastroenterol; 2017 Nov; 33(6):473-476. PubMed ID: 28877045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy in esophagogastric cancer.
    Ilson DH
    Clin Adv Hematol Oncol; 2021 Oct; 19(10):639-647. PubMed ID: 34637430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial.
    Janjigian YY; Maron SB; Chatila WK; Millang B; Chavan SS; Alterman C; Chou JF; Segal MF; Simmons MZ; Momtaz P; Shcherba M; Ku GY; Zervoudakis A; Won ES; Kelsen DP; Ilson DH; Nagy RJ; Lanman RB; Ptashkin RN; Donoghue MTA; Capanu M; Taylor BS; Solit DB; Schultz N; Hechtman JF
    Lancet Oncol; 2020 Jun; 21(6):821-831. PubMed ID: 32437664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress and current challenges of immunotherapy in advanced/metastatic esophagogastric adenocarcinoma.
    Moehler M; Högner A; Wagner AD; Obermannova R; Alsina M; Thuss-Patience P; van Laarhoven H; Smyth E
    Eur J Cancer; 2022 Nov; 176():13-29. PubMed ID: 36183651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectivity of targeted therapy and immunotherapy in patients with advanced metastatic and non-metastatic cancer of the esophagus and esophago-gastric junction.
    Valkema MJ; Mostert B; Lagarde SM; Wijnhoven BPL; van Lanschot JJB
    Updates Surg; 2023 Feb; 75(2):313-323. PubMed ID: 35836094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What's new in gastric cancer?].
    Masetti M; Lorenzen S
    Dtsch Med Wochenschr; 2024 Aug; 149(17):1015-1020. PubMed ID: 39146748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT.
    Liu X; Jin J; Cai H; Huang H; Zhao G; Zhou Y; Wu J; Du C; Long Z; Fang Y; Ma M; Li G; Zhou M; Yin J; Zhu X; Zhu J; Sheng W; Huang D; Zhu H; Zhang Z; Lu Q; Xie L; Zhang Z; Wang Y
    BMC Cancer; 2019 Jun; 19(1):606. PubMed ID: 31221115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update in the nonendoscopic treatment of gastric cancer.
    Ilson DH
    Curr Opin Gastroenterol; 2016 Nov; 32(6):501-506. PubMed ID: 27636304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Claudin18.2 in Advanced Gastric Cancer.
    Inamoto R; Takahashi N; Yamada Y
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.